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INTRODUCTION: 
Arthritis is a major syndrome affecting majority of the 
geriatric patients and generally NSAID’S are advised to 
reduce pain and inflammation
1
. The medications 
prescribed for the relief of inflammat ion and associated 
pain are availab le as conventional dosages like tablets and 
capsules. The conventional medications cause GI 
disturbances and drug level fluctuates considerable making 
the patient to suffer or the patient is burdened with over-
dosage
2
. To minimize the GI disturbances and to improve 
the bioavailability of the drug certain novel dosage forms 
are being investigated. In the past two decades there has 
been a commendable growth both in size and to improve 
bioavailability and patient compliance. Transdermal drug 
delivery systems (TDDS) are designed to support the 
passage of drug substances from the surface of skin, 
through its various layers, into the systemic circulation. 
Their advantages over conventional dosage forms include 
improved patient compliance, avoidance of gastric 
irritation and first-pass effect and controlled therapeutic 
responses
3
. Ketoprofen, a non-steroidal anti-inflammatory  
drug, used in the treatment of arthritis, can be used as a 
suitable model to develop TDDS because of its short half-
life of about 2-3 hr and gastro-intestinal side effects 
4
. 
MATERIALS AND METHODS: 
Ketoprofen was gift sample Themis laboratories Mumbai,  
HPMC and EC were  gift samples from Ajanta 
Pharmaceuticals Mumbai, d-limonene, oleic acid were 
obtained from sd-fine chemicals. All the other reagents 
used were of analytical g rade. HPMC and EC are  
hydrophilic and hydrophobic polymers respectively, to see 
their effect on release of ketoprofen through skin, so both 
the polymers are chosen for the present study. 
Drug polymer interaction by FT-IR
5, 6 
: 
To investigate any possible interaction between the drug 
and the utilized polymer, IR spectrum of pure drug and its 
physical mixture was carried out by using FT-IR (Perkin  
elmer 1600 series USA) the range selected was from 
400cm
-1
 to 4000cm
-1
.  
Preparation of monolithic trans dermal  systems: 
Monolithic transdermal systems of HPMC and EC were 
prepared by solvent casting method on mercury surface as 
per mundane et al method
7
. Various formulat ions with 
their codes is tabulated in table 1. Polymeric solution was 
prepared by dissolving the respective polymer in  
combination of solvents, stirred on magnetic stirrer for 20 
min with simultaneous addition of gylcerine and dibutyl 
phthalate as plasticizers for HPMC and EC patches 
respectively. Specific quantity of drug was dissolved in 
alcohol and added to the polymeric solution. Finally the 
resulting solution was poured within a glass bangle of 5cm 
diameter placed on mercury surface in a petridish. The rate 
of evaporation of the solvent was controlled by inverting 
cut funnel over the petridish. After 24 hr the dried patches 
were taken out and stored in a desiccator. The drug 
polymer ratio was 1:4 respectively and was kept constant 
for all the formulations. Various formulat ions prepared are 
depicted in table 1. 
 
ABSTRACT: 
Transdermal drug delivery systems of ketoprofen have been formulated using solvent casting method. matrix type 
transdermal systems were prepared by using Hydroxy propyl methyl cellulose (HPMC) and ethyl cellulose (EC)  
polymers by incorporation glycerin and dibutyl phthalate as plasticizers respectively. Drug polymer interactions were 
studied by FT-IR and differential scanning calorimetry which showed no interaction between drug and the polymers used. 
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by scanning electron microscopy which showed uniform distribution of drug throughout the patch. The in vitro drug 
release studies indicated that HPMC and EC patches with no permeation enhancer released the drug in an optimum rate. 
The various permeation parameters such as flux, permeability co-efficient, enhancement ration and diffusion rate 
constants were determined for all the formulations. The effect of permeation enhancer on the diffusion of ketoprofen 
across rat skin was determined. The maximum flux of 9.52x10-2 mg/cm2/hr was observed with HPMC monolithic system 
containing 5% v/v d-limonene. A significant improvement of flux was observed with 5% d-limonene than that of 20% 
oleic acid. The in vitro release studies revealed that the release was sustained upto 24 hr and followed zero order kinetics.  
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 Table 1: Formulation Codes of Various Monolithic Transdermal Patches Containing Ketoprofen 
Note: The above formulae gives total area of 19.63 sq. cm 
Methodology: 
Physical appearance, weight and Thickness uniformity: 
All the transdermal patches were visually inspected for 
color, clarity, flexib ility and smoothness. The dried 
patches were weighed on afcoset digital balance. The 
average of five observations was  taken. The thickness
8
 was 
measured by a screw gauge (mitutoyo Japan) at five 
different random points on the patch. The average of five 
observations was taken. 
Table 2: Physical parameters of the transdermal systems  
S.No. Formulat ion codes Physical appearance Weight (mg) Thickness (mm) 
1 F1 ++ 272.2(0.49) 0.167(0.0067) 
2 F2 ++ 275.1(0.32) 0.147(0.0044) 
3 F3 ++ 279.5(0.35) 0.129(0.0022) 
4 F4 ++ 291.7(0.42) 0.149(0.0044) 
5 F5 ++ 315.1(0.34) 0.149(0.0102) 
6 F6 ++ 325(0.44) 0.167(0.0067) 
 
Water vapor transmission studies (WVT)
 9
: 
Glass vials of equal diameter were used as transmission 
cells. These cells were washed and dried in an oven. About 
1gm of fused calcium chloride was taken in the cells and 
patch of area equivalent to brim of vial (1.36 cm
2
) was 
fixed with the help of an adhesive. The cells were weighed 
accurately and kept in a close desiccator containing 
saturated solution of potassium bromide (200ml). The 
humid ity inside the desiccator was measured by a 
hygrometer and it was found to be 84% RH. The cells 
were taken out and weighed after 1, 2, 3, 4, 5, 6 and 7 days 
of storage. The WVT was calcu lated by taking the 
difference in the weight of the patches before and at 
regular intervals of 24 hr for a total period of seven days.
 
Table 3: Data for water vapor transmission studies for monolithic systems . 
S.No. 
Formulat ion 
codes 
Cumulat ive amount of water vapour transmitted in gms WVT rate 
constant 
(gm/24hr/sq) 
1
st
 day 2
nd
 day 3
rd
 day 4
th
 day 5
th
 day 6
th
 day 7
th
 day 
1 F1 0.045 0.089 0.133 0.177 0.221 0.264 0.307 3.307x10
-2
 
2 F2 0.050 0.105 0.157 0.209 0.26 0.311 0.384 4.137x10
-2
 
3 F3 0.049 0.099 0.147 0.195 0.243 0.291 0.362 3.900x10
-2
 
4 F4 0.034 0.069 0.097 0.139 0.176 0.211 0.245 2.600x10
-2
 
5 F5 0.038 0.076 0.113 0.15 0.188 0.225 0.262 2.820x10
-2
 
6 F6 0.036 0.072 0.107 0.142 0.174 0.231 0.248 2.671x10
-2
 
 
Drug content uniformity
10
: 
Transdermal films of 1sq.cm area was cut into small piece 
and transferred into 100ml volumetric flask. 25ml of 
methanol was added and shaken for 4hr to extract the drug. 
Finally, suitable d ilutions were made using phosphate 
buffer pH 7.4 and absorbance was measured at 258nm. 
In vitro permeation across the rat abdominal  skin: 
Preparation of the skin
11
: 
The swiss albino rats were sacrificed by decapituation. The 
fresh abdominal skin  was excised from swiss albino rats 
weighing 170-190gm. The abdominal skin of excised 
hairless rat skin was separated along the epidermal 
junction and was kept under a steam of 60 
0
C water for 
exactly 50 seconds. The heat-treated skin was cleared of its 
subcutaneous fatty substances and immediately kept in  
normal saline solution to flatten and smooth. This step 
maintains the integrity and viability of the skin.  
S.No. Ingredients (mg/ml) Formulat ion codes 
F1 F2 F3 F4 F5 F6 
1 Ketoprofen 50 50 50 50 50 50 
2 HPMC 200 200 200 - - - 
3 EC - - - 200 200 200 
4 Dibutyl phthalate - - - 0.0575 0.0575 0.0575 
5 Glycerine  0.0585 0.0585 0.0585 - - - 
6 d-limonene - 0.0029 - - 0.0029 - 
7 Oleic acid - - 0.0111 - - 0.0111 
8 Alcohol 2 2 2 2 2 2 
9 Dich loromethane 1 1 1 1 1 1 
10 Chloroform 2 2 2 2 2 2 
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Permeation studies: 
A vertically assembled Keshary-Chien12 diffusion cell 
having downstream volume of 50ml was  used. The above 
skin was mounted on the diffusion cell and receiver 
compartment was filled with 50ml phosphate buffer of pH 
7.4 and the temperature was maintained at 37 
0
C. The 
samples were withdrawn every hour (replaced with 1ml 
fresh buffer to maintain sink condition) and their 
concentrations were measured in UV-spectrophotometer at 
254nm. The permeation studies were carried out upto 24hr. 
RES ULTS AND DISCUSS ION 
Fig 1, 2 and 3 shows the IR spectra of pure drug 
ketoprofen and the physical mixture o f ketoprofen with 
HPMC polymer and EC po lymer. Due to replication of 
peaks in IR spectra of physical mixture (fig 2 and 3) as that 
of pure drug ketoprofen (fig1) indicate their compatib ility.   
 
 
Figure 1: IR of Ketoprofen 
 
Figure 2: IR of ketoprofen and HPMC mixture  
 
Figure 3: IR of ketoprofen and EC 
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In the next step, a total of 6 formulations of monolithic and 
reservoirs were prepared using HPMC and EC polymers as 
per formulae given in table 1. A ll the films evaluated for 
their physical parameters were found to be flexib le, 
smooth and transparent. They were also found to be 
uniform in their weight and thickness with low SD values 
as shown in table 2. 
The WVT studies (table 3) depicted that all the 
formulat ions from F1 to F6 were permeable to water 
vapour and among all the formulations HPMC containing 
patches showed good WVT than that of EC patches. The 
drug content was almost uniform in all the patches with 
low SD values (table 5). 
The in vitro release of drug across rat skin from HPMC 
and EC showed only 57.66% 
( F1) and 43.11% (F4) at the end of 24
th
 hr respectively 
(Fig 4), the flux was calculated from the slope of linear 
graph and it was found to be 6.13x10
-2
 and 4.59x10
-2
 
mg/cm
2
/hr, diffusion rate constants were 0.23 and 0.172 
mg/hr/cm
2
 respectively (table 5). It was evident from the 
above result that there was a lower flux, poor drug 
permeability and less diffusion which might be attributed 
to tough barrier, stratum corneum of the skin; hence there 
was a need to incorporate permeat ion enhancer in the 
system. Two permeat ion enhancers  namely d-limonene
13
 
(5% v/v) and oleic acid
14
 (20% v/v) were incorporated and 
the drug release was studies. Among these systems, patch 
containing d-limonene in HPMC polymer (F2) showed 
maximum release, whereas patch containing d-limonene in 
EC polymer (F5) showed less release at the end of 24hr. In  
the later study, 20% o leic acid was used as polymer in both 
HPMC (F3) and EC polymer (F6) among which 20% oleic 
acid in HPMC polymer showed more release. On the 
whole, HPMC polymer showed more release than oleic 
acid (Fig 5). 
 
Table 4: Comparative kinetic values of drug release from trans dermal monolithic and reservoir systems. 
S.No. Formulation codes 
Zero order equation Higuchi’s equation  
N R N R 
1 F1 2.3323 0.9968 11.3516 0.9352 
2 F2 3.8781 0.895 22.6712 0.9375 
3 F3 3.6614 0.898 20.778 0.9517 
4 F4 1.7153 0.9952 8.557 0.9546 
5 F5 3.1247 0.9963 15.440 0.9477 
6 F6 3.0186 0.9981 14.952 0.9501 
 
Table 5: Permeability co-efficient, flux, enhancement ratio and diffusion rate constant of transdermal monolithic 
system 
S.No. 
Formulation 
codes 
Permeability co-
efficient 
mg.mm/hr 
Flux 
mg/cm
2
 /hr 
Drug Content 
Enhancement 
ratio 
Diffusion rate 
constant 
mg/hr/cm
2
 
1 F1 2.56x10
-2
 6.13x10
-2
 98.5 (0.25) - 0.230 
2 F2 4,001x10
-2
 9.52x10
-2
 99.1 (0.35) 1.55 0.358 
3 F3 3.632x10
-2
 8.68x10
-2
 98.9 (0.37) 1.45 0.326 
4 F4 1.927x10
-2
 4.59x10
-2
 97.2 (0.27) - 0.173 
5 F5 3.402x10
-2
 8.10x10
-2
 98.1 (0.36) 1.32 0.305 
6 F6 3.326x10
-2
 7.77x10
-2
 97.8 (0.41) 1.26 0.292 
 
 
Figure 4: In Vitro Drug Release from Formulations F1 
and F2 across Rat Abdominal Skin 
 
 
Figure 5: In Vitro Drug Release from Formulations F2, 
F3, F5  and F6  Across Rat Abdominal Skin 
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CONCLUS IONS: 
The fabricated polymeric films containing ketoprofen had 
shown uniform thickness, weight variation and drug 
content. In vitro skin permeat ion profile of the films was 
fairly uniform.  Among two permeation enhancers d-
limonene showed significant enhancement of drug 
permeat ion than oleic acid. The results of the study 
indicate the feasibility of formulat ing rate controlled  
transdermal therapeutic systems of ketoprofen for effective 
management of chronic pain, inflammation associated with 
rheumatoid and osteoarthritis conditions.  
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